×
About 10,839 results

ALLMedicine™ Helicobacter Pylori Infection Center

Research & Reviews  5,167 results

Features That Aid Identification of Autoimmune Gastritis in a Background of Active Heli...
https://doi.org/10.5858/arpa.2020-0615-OA
Archives of Pathology & Laboratory Medicine; Choudhuri J, Hall S et. al.

Feb 26th, 2021 - Helicobacter pylori-associated and autoimmune gastritis may coexist in a subset of patients who require treatment for both disorders. To delineate findings that identify autoimmune gastritis in the background of H pylori infection. We examined cas...

Clinical Significance of Helicobacter pylori Infection on Psoriasis Severity.
https://doi.org/10.1089/jir.2020.0144
Journal of Interferon & Cytokine Research : the Official ... Ahmed AS, Al-Najjar AH et. al.

Feb 23rd, 2021 - The aim of the study was to appraise the link between psoriasis and Helicobacter pylori, investigate the influence of H. pylori treatment on psoriasis severity, determine the cutoff value of haptoglobin as a psoriatic biomarker, and determine the ...

GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointe...
https://doi.org/10.1038/s41467-021-21280-7 10.1053/j.gastro.2018.08.063 10.1136/gut.2006.117598 10.1053/gast.2002.32392 10.1111/j.1572-0241.2006.00630.x 10.1016/S0140-6736(16)32404-7 10.1111/apt.12465 10.1111/nmo.13017 10.1136/gutjnl-2012-304269 10.1056/NEJMra1207068 10.1038/nrgastro.2015.34 10.1016/S0140-6736(17)32448-0 10.1001/archinte.160.1.105 10.1136/gut.52.8.1085 10.1016/j.gtc.2010.12.011 10.1093/hmg/ddu174 10.1002/cti2.1001 10.1038/ng.1109 10.1038/s41467-019-11968-2 10.1136/gutjnl-2014-307997 10.1038/ajg.2014.56 10.1053/j.gastro.2018.03.064 10.1126/scitranslmed.aap8914 10.1038/nrn3071 10.1038/nrgastro.2012.32 10.1136/gut.47.6.861 10.1097/MD.0000000000002333 10.3748/wjg.v21.i14.4302 10.1007/s00406-014-0502-z 10.1136/gut.2003.019844 10.1016/j.ajhg.2010.11.011 10.1038/ng.2213 10.1534/genetics.115.178616 10.1038/s41467-017-02317-2 10.1038/s41467-017-01261-5 10.1093/nar/gkw1133 10.1038/ng.3211 10.1093/bioinformatics/btw613 10.1038/s41588-018-0269-7 10.1038/s41588-018-0059-2 10.1038/mp.2015.197 10.1038/mp.2017.77 10.1038/s41588-019-0397-8 10.1038/s41588-019-0344-8 10.1038/s41588-018-0090-3 10.1038/s41398-018-0150-6 10.1016/S1474-4422(19)30320-5 10.1038/ng.3552 10.1038/ng.3888 10.1038/ng.3749 10.1038/nature14177 10.1038/nature14132 10.1038/ng.3396 10.1038/ng.2383 10.1038/nature17671 10.1038/s41588-018-0081-4 10.1126/science.1262110 10.1038/ng.3173 10.1038/s41588-018-0147-3 10.1038/s41588-018-0307-5 10.1038/ng.3538 10.1038/s41598-018-35871-w 10.1038/nature14248 10.1371/journal.pcbi.1004219 10.1038/s41588-020-0594-5 10.1038/s41588-018-0255-0 10.18632/oncotarget.23278 10.1093/aje/kwq299 10.1371/journal.pgen.1000072 10.1038/srep25575 10.12688/wellcomeopenres.14636.2 10.1053/j.gastro.2007.07.003 10.3748/wjg.v21.i31.9430 10.4172/2161-069X.1000123 10.1158/0008-5472.CAN-15-2272 10.1016/j.jns.2016.03.005 10.1517/14728214.2015.1049996 10.1038/ng.2796 10.1073/pnas.1911429116 10.1172/JCI76307 10.1136/gut.51.6.885 10.1016/j.amjsurg.2013.02.012 10.1038/s41598-018-29629-7 10.1038/s41467-019-09572-5 10.1046/j.1442-2050.2002.00261.x 10.1159/000485190 10.1056/NEJMoa1915784 10.1111/j.1365-2036.2008.03596.x 10.1017/S0033291717000745 10.1093/ije/dyx206 10.1038/s41586-018-0579-z 10.1093/hmg/ddy271 10.1186/s13742-015-0047-8 10.1136/gut.2010.224154 10.1038/nrd.2016.230 10.1093/bioinformatics/btq559 10.3389/fgene.2012.00118 10.1111/j.1469-1809.1965.tb00500.x 10.1111/j.1469-1809.1972.tb00767.x 10.1038/s41588-018-0144-6 10.1534/genetics.117.300360 10.1093/bioinformatics/btq419 10.1186/s12864-015-2347-x 10.1038/ng.3406 10.1038/ng.3404 10.1101/gr.229102 10.1038/nature10530 10.1038/nature11247 10.1038/s41467-018-04558-1 10.1073/pnas.0506580102 10.1016/j.cels.2015.12.004 10.1002/gepi.21758 10.1093/ije/dyv080 10.1002/gepi.21965 10.1038/s41588-018-0099-7 10.1186/1471-2105-12-77
Nature Communications; Wu Y, Murray GK et. al.

Feb 20th, 2021 - Genetic factors are recognized to contribute to peptic ulcer disease (PUD) and other gastrointestinal diseases, such as gastro-oesophageal reflux disease (GORD), irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Here, genome-wid...

Preliminary single-center experience of Helicobacter pylori eradication among the liver...
https://doi.org/10.1111/hel.12791
Helicobacter Xie M, Li Q et. al.

Feb 18th, 2021 - To investigate the prevalence of Helicobacter pylori infection among orthotopic liver transplant (LT) recipients and explore the efficacy and safety of H. pylori eradication therapy. Liver transplant recipients receiving regular follow-up in our c...

Helicobacter pylori infection is associated with the co-occurrence of bacteria in the o...
https://doi.org/10.1111/hel.12786
Helicobacter Wu ZF, Zou K et. al.

Feb 17th, 2021 - Pathogens capable of impacting gastrointestinal tract tumor development are located in the oral cavity, but whether these oral bacteria are able to colonize the gastric mucosa in gastric cancer (GC) patients and whether Helicobacter pylori infecti...

see more →

Guidelines  31 results

AGA Clinical Practice Update on The Management of Refractory Helicobacter pylori Infect...
https://doi.org/10.1053/j.gastro.2020.11.059
Gastroenterology Shah SC, Iyer PG et. al.

Feb 1st, 2021 - The purpose of this CPU Expert Review is to provide clinicians with guidance on the management of H. pylori after an initial attempt at eradication therapy fails, including best practice advice on specific regimen selection, and consideration of p...

British Society of Gastroenterology guidelines on the diagnosis and management of patie...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709778
Gut Banks M, Graham D et. al.

Jul 6th, 2019 - Gastric adenocarcinoma carries a poor prognosis, in part due to the late stage of diagnosis. Risk factors include Helicobacter pylori infection, family history of gastric cancer-in particular, hereditary diffuse gastric cancer and pernicious anaem...

H. pylori Infection: ACG Updates Treatment Recommendations
https://www.aafp.org/afp/2018/0115/p135.html

Jan 14th, 2018 - Helicobacter pylori infection is one of the most common chronic bacterial infections. The American College of Gastroenterology (ACG) has updated its clinical guidelines in response to significant scientific advances in the management of this disea...

Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children...
https://doi.org/10.1097/MPG.0000000000001594
Journal of Pediatric Gastroenterology and Nutrition; Jones NL, Koletzko S et. al.

May 25th, 2017 - Because of the changing epidemiology of Helicobacter pylori infection and low efficacy of currently recommended therapies, an update of the European Society for Paediatric Gastroenterology Hepatology and Nutrition/North American Society for Pediat...

Management of Dyspepsia: ACG guidelines
http://gi.org/guideline/management-of-dyspepsia-2/
Moayyedi PM

Mar 27th, 2017 - We have updated both the American College of Gastroenterology (ACG) and the Canadian Association of Gastroenterology (CAG) guidelines on dyspepsia in a joint ACG/CAG dyspepsia guideline. We suggest that patients ?60 years of age presenting with dy.

see more →

Drugs  117 results see all →

Clinicaltrials.gov  5,375 results

Features That Aid Identification of Autoimmune Gastritis in a Background of Active Heli...
https://doi.org/10.5858/arpa.2020-0615-OA
Archives of Pathology & Laboratory Medicine; Choudhuri J, Hall S et. al.

Feb 26th, 2021 - Helicobacter pylori-associated and autoimmune gastritis may coexist in a subset of patients who require treatment for both disorders. To delineate findings that identify autoimmune gastritis in the background of H pylori infection. We examined cas...

Clinical Significance of Helicobacter pylori Infection on Psoriasis Severity.
https://doi.org/10.1089/jir.2020.0144
Journal of Interferon & Cytokine Research : the Official ... Ahmed AS, Al-Najjar AH et. al.

Feb 23rd, 2021 - The aim of the study was to appraise the link between psoriasis and Helicobacter pylori, investigate the influence of H. pylori treatment on psoriasis severity, determine the cutoff value of haptoglobin as a psoriatic biomarker, and determine the ...

Clarithromycin - clarithromycin for suspension-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fad1e5a3-59f9-4868-9937-d3b061ab8f00

Feb 21st, 2021 - Clarithromycin is a macrolide antimicrobial indicated for mild to moderate infections caused by designated, susceptible bacteria in the following: •Acute Bacterial Exacerbation of Chronic Bronchitis in Adults (1.1) •Acute Maxillary Sinusitis (1.2)...

GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointe...
https://doi.org/10.1038/s41467-021-21280-7 10.1053/j.gastro.2018.08.063 10.1136/gut.2006.117598 10.1053/gast.2002.32392 10.1111/j.1572-0241.2006.00630.x 10.1016/S0140-6736(16)32404-7 10.1111/apt.12465 10.1111/nmo.13017 10.1136/gutjnl-2012-304269 10.1056/NEJMra1207068 10.1038/nrgastro.2015.34 10.1016/S0140-6736(17)32448-0 10.1001/archinte.160.1.105 10.1136/gut.52.8.1085 10.1016/j.gtc.2010.12.011 10.1093/hmg/ddu174 10.1002/cti2.1001 10.1038/ng.1109 10.1038/s41467-019-11968-2 10.1136/gutjnl-2014-307997 10.1038/ajg.2014.56 10.1053/j.gastro.2018.03.064 10.1126/scitranslmed.aap8914 10.1038/nrn3071 10.1038/nrgastro.2012.32 10.1136/gut.47.6.861 10.1097/MD.0000000000002333 10.3748/wjg.v21.i14.4302 10.1007/s00406-014-0502-z 10.1136/gut.2003.019844 10.1016/j.ajhg.2010.11.011 10.1038/ng.2213 10.1534/genetics.115.178616 10.1038/s41467-017-02317-2 10.1038/s41467-017-01261-5 10.1093/nar/gkw1133 10.1038/ng.3211 10.1093/bioinformatics/btw613 10.1038/s41588-018-0269-7 10.1038/s41588-018-0059-2 10.1038/mp.2015.197 10.1038/mp.2017.77 10.1038/s41588-019-0397-8 10.1038/s41588-019-0344-8 10.1038/s41588-018-0090-3 10.1038/s41398-018-0150-6 10.1016/S1474-4422(19)30320-5 10.1038/ng.3552 10.1038/ng.3888 10.1038/ng.3749 10.1038/nature14177 10.1038/nature14132 10.1038/ng.3396 10.1038/ng.2383 10.1038/nature17671 10.1038/s41588-018-0081-4 10.1126/science.1262110 10.1038/ng.3173 10.1038/s41588-018-0147-3 10.1038/s41588-018-0307-5 10.1038/ng.3538 10.1038/s41598-018-35871-w 10.1038/nature14248 10.1371/journal.pcbi.1004219 10.1038/s41588-020-0594-5 10.1038/s41588-018-0255-0 10.18632/oncotarget.23278 10.1093/aje/kwq299 10.1371/journal.pgen.1000072 10.1038/srep25575 10.12688/wellcomeopenres.14636.2 10.1053/j.gastro.2007.07.003 10.3748/wjg.v21.i31.9430 10.4172/2161-069X.1000123 10.1158/0008-5472.CAN-15-2272 10.1016/j.jns.2016.03.005 10.1517/14728214.2015.1049996 10.1038/ng.2796 10.1073/pnas.1911429116 10.1172/JCI76307 10.1136/gut.51.6.885 10.1016/j.amjsurg.2013.02.012 10.1038/s41598-018-29629-7 10.1038/s41467-019-09572-5 10.1046/j.1442-2050.2002.00261.x 10.1159/000485190 10.1056/NEJMoa1915784 10.1111/j.1365-2036.2008.03596.x 10.1017/S0033291717000745 10.1093/ije/dyx206 10.1038/s41586-018-0579-z 10.1093/hmg/ddy271 10.1186/s13742-015-0047-8 10.1136/gut.2010.224154 10.1038/nrd.2016.230 10.1093/bioinformatics/btq559 10.3389/fgene.2012.00118 10.1111/j.1469-1809.1965.tb00500.x 10.1111/j.1469-1809.1972.tb00767.x 10.1038/s41588-018-0144-6 10.1534/genetics.117.300360 10.1093/bioinformatics/btq419 10.1186/s12864-015-2347-x 10.1038/ng.3406 10.1038/ng.3404 10.1101/gr.229102 10.1038/nature10530 10.1038/nature11247 10.1038/s41467-018-04558-1 10.1073/pnas.0506580102 10.1016/j.cels.2015.12.004 10.1002/gepi.21758 10.1093/ije/dyv080 10.1002/gepi.21965 10.1038/s41588-018-0099-7 10.1186/1471-2105-12-77
Nature Communications; Wu Y, Murray GK et. al.

Feb 20th, 2021 - Genetic factors are recognized to contribute to peptic ulcer disease (PUD) and other gastrointestinal diseases, such as gastro-oesophageal reflux disease (GORD), irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Here, genome-wid...

Preliminary single-center experience of Helicobacter pylori eradication among the liver...
https://doi.org/10.1111/hel.12791
Helicobacter Xie M, Li Q et. al.

Feb 18th, 2021 - To investigate the prevalence of Helicobacter pylori infection among orthotopic liver transplant (LT) recipients and explore the efficacy and safety of H. pylori eradication therapy. Liver transplant recipients receiving regular follow-up in our c...

see more →

News  147 results

H Pylori Eradication Testing Less Likely in Black Patients
https://www.medscape.com/viewarticle/940437

Nov 4th, 2020 - Black patients may be significantly less likely to receive eradication testing after treatment for Helicobacter pylori infection than patients of other races/ethnic groups, based on a retrospective analysis of more than 1,700 individuals. This dis...

H pylori Therapy Reduces Gastric Cancer in High-Risk Patients
https://www.medscape.com/viewarticle/924545

Jan 29th, 2020 - UPDATED with comments  January 31, 2020 // Treatment of Helicobacter pylori infection in patients with a family history of gastric cancer more than halves their risk of developing gastric cancer, according to the results of a large-scale, long-ter...

Eradicating H. pylori may cut risk of gastric cancer
https://www.mdedge.com/internalmedicine/article/215391/gastroenterology/eradicating-h-pylori-may-cut-risk-gastric-cancer?channel=39313
Amy Karon

Jan 11th, 2020 - Eradication of Helicobacter pylori infection was associated with a more than 75% decrease in hazard of subsequent stomach cancer in a large retrospective cohort study. Simply being treated for H.

Rifabutin-based triple therapy for H. pylori gets high marks
https://www.mdedge.com/fedprac/article/212265/gastroenterology/rifabutin-based-triple-therapy-h-pylori-gets-high-marks?channel=234
Bruce Jancin

Nov 13th, 2019 - SAN ANTONIO – The first new treatment for Helicobacter pylori infection to receive Food and Drug Administration approval in 22 years performed so well in a pivotal phase 3 trial that it is worthy of consideration as best-in-class first-line therap.

Two studies reveal preneoplastic links between H. pylori and gastric cancer
https://www.mdedge.com/gihepnews/article/209268/gastroenterology/two-studies-reveal-preneoplastic-links-between-h-pylori?channel=69
Will Pass, MDedge News

Oct 2nd, 2019 - Molecular pathways linked with CD44 variant 9 (CD44v9), a cell surface glycoprotein tied to aggressive gastric cancer after Helicobacter pylori infection, may open doors to stop cancer before it starts, according to two recent studies. Findings fr.

see more →

Patient Education  2 results see all →